What The Study Did: The large health care system Kaiser Permanente Northern California provides universal screening for prenatal cannabis use in women during pregnancy by self-report and urine toxicology testing. This observational study used data to examine the association of depression, anxiety, and trauma diagnoses and symptoms with cannabis use by women during pregnancy.
To access the embargoed study: Visit our For The Media website at this link https:/
Authors: Kelly C. Young-Wolff, Ph.D., M.P.H., of Kaiser Permanente Northern California in Oakland, is the corresponding author.
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. Every Wednesday and Friday, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.